1. Spark Therapeutics Announces Addition of Lota Zoth to Its Board of Directors

    Spark Therapeutics Announces Addition of Lota Zoth to Its Board of Directors

    Spark Therapeutics, Inc. announced today that Lota Zoth, CPA, a long-time financial executive at multiple publicly listed companies, has been named to the company’ s Board of Directors. Ms. Zoth has served in senior financial roles in a variety of commercial-stage companies over a 30-year career, including serving as Chief Financial Officer for MedImmune ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. As we advance toward becoming a commercial-stage company we will benefit enormously from the addition of Lota's experience and perspective to our Board.
    2. With a recently completed successful pivotal trial in its lead indication and progress throughout the pipeline, Spark is in a strong position to lead the field of gene therapy for many years to come.
  3. Topics Mentioned